Formulation and Packaging Sample Clauses

The 'Formulation and Packaging' clause defines the requirements and standards for how a product must be composed and prepared for sale or distribution. It typically outlines specifications for ingredients, manufacturing processes, packaging materials, and labeling to ensure consistency and compliance with regulatory or contractual obligations. By setting clear expectations for both formulation and packaging, this clause helps prevent disputes over product quality and presentation, ensuring that all parties understand and meet the agreed-upon standards.
Formulation and Packaging. In all events, NOVARTIS will be responsible for formulation and packaging of Drug Products.
View SourceView Similar (3)
Formulation and Packaging. ‌ Sufficient quantities of VI-0521, phentermine and topiramate capsules will be supplied by the sponsor in blister cards and bottles and shipped to a designee at the study site. All clinical supplies will be labeled with information required by national and/or international regulations. Study drug will be packaged into 2 types of kits; titration kits (blister cards) for use during the first 4 weeks of study treatment and the titration period during study Weeks 13-16, and treatment kits (bottles), for use once subjects have been titrated to their assigned dose. Each titration kit contains 1 blister card for use during Weeks 1 through 4 of titration, with each card containing 4 columns of 8 capsules each. Each column on the blister card will be labeled with the week number (1 through 4) and will contain capsules with the dose specified for that week of treatment, as outlined in Table 1. Titration kits will consist of blister cards labeled with the study number, a unique kit number, storage instructions, and spaces for the subject number and initials. Treatment kits will consist of bottles, each containing 35 capsules of study medication at the treatment dosages shown in Table 1. Each kit will contain a single bottle labeled with the study number, a unique kit number, storage instruction, and spaces for the subject number and initials. Table 1: VI-0521 Dosage Strengths by Titration Week for Each Treatment Group‌
View Source
Formulation and Packaging. QLT shall be responsible for formulation and packaging of Collaboration Products, including the costs thereof. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
View Source
Formulation and Packaging. Chelsea shall at its sole cost, expense, risk and responsibility carry out the formulation and packaging of the Finished Product. The formulation and packaging shall be carried out in compliance with any and all applicable laws and regulations of the Territory. Chelsea shall not sell, by itself through its Affiliates and Sublicensees, the Finished Product which does not meet the then-prevailing quality, specifications and test methods, formula and manufacturing process. Chelsea shall at DSP’s request and Chelsea’s expense, provide DSP with an appropriate unit of samples of the Finished Product, together with manufacturing report including certificate of analysis.
View Source

Related to Formulation and Packaging

  • Packaging Tangible product shall be securely and properly packed for shipment, storage, and stocking in appropriate, clearly labeled, shipping containers and according to accepted commercial practice, without extra charge for packing materials, cases, or other types of containers. All containers and packaging shall become and remain Customer’s property.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time. (b) The Supplier shall not change any process, material, component, packaging or manufacturing location without the Purchaser’s express prior written approval.

  • Packaging and Labeling Seller shall properly ▇▇▇▇, ▇▇▇▇, and ship Goods and provide Buyer with shipment documentation showing the Order number, Seller’s identification number for the subject Goods, the quantity of goods in shipment and the number of cartons or containers in the shipment.

  • Labelling A label shall be permanently affixed on each container with at least the following information: name of the manufacturer, serial number, date of manufacture, MFP, NWP, type of fuel (e.g. "

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.